U. Pohlen
Impact in
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis
-
- Colorectal Cancer Surgical Treatments
- Colorectal Cancer Treatments and Studies
- Colorectal Cancer Screening and Detection
Papers in
- Hepatology 14
- Hepatocellular Carcinoma Treatment and Prognosis 14
- Oncology 13
- Colorectal Cancer Treatments and Studies 6
- Colorectal Cancer Surgical Treatments 4
- Pancreatic and Hepatic Oncology Research 4
- Co-authors
- H. J. Buhr (20 shared papers)G. Berger (14 shared papers)M. Kruschewski (3 shared papers)Hubert G. Hotz (2 shared papers)Regina Reszka (8 shared papers)Christoph Holmer (5 shared papers)Mike Parker (1 shared paper)Christoph Loddenkemper (3 shared papers)
- Journals
- International Journal of Colorectal Disease (3 papers)Investigational New Drugs (2 papers)Journal of Surgical Research (2 papers)Chemotherapy (2 papers)World Journal of Surgery (1 paper)
- Partner nations
- GermanyUnited StatesNetherlands
In The Last Decade
U. Pohlen
30 papers receiving 390 citations
Peers
Comparison fields: 5 of 62
- Hepatology 98
- Oncology 197
- Surgery 186
- Pulmonary and Respiratory Medicine 114
- Biomaterials 33
Countries citing papers authored by U. Pohlen
This map shows the geographic impact of U. Pohlen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by U. Pohlen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites U. Pohlen more than expected).
Fields of papers citing papers by U. Pohlen
This network shows the impact of papers produced by U. Pohlen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by U. Pohlen. The network helps show where U. Pohlen may publish in the future.
Co-authors
The 25 scholars most cited alongside U. Pohlen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 104 | |
| 2 | Evaluation of efficient chemoembolization mixtures by magnetic resonance imaging therapy monitoring: an experimental study on the VX2 tumor in the rabbit liver. | 1996 | 33 |
| 3 | 2012 | 27 | |
| 4 | 2008 | 23 | |
| 5 | 1997 | 23 | |
| 6 | 2000 | 23 | |
| 7 | Multicenter pilot study of 5-fluorouracil, folinic acid, interferon alpha-2b and degradable starch microspheres via hepatic arterial infusion in patients with nonresectable colorectal liver metastases. | 2004 | 15 |
| 8 | 2013 | 14 | |
| 9 | Chemoembolization of lung metastases--pharmacokinetic behaviour of carboplatin in a rat model. | 2007 | 13 |
| 10 | Hepatic arterial infusion (HAI). Comparison of 5-fluorouracil, folinic acid, interferon alpha-2b and degradable starch microspheres versus 5-fluorouracil and folinic acid in patients with non-resectable colorectal liver metastases. | 2006 | 13 |
| 11 | 2002 | 12 | |
| 12 | 2011 | 11 | |
| 13 | 2012 | 11 | |
| 14 | 1999 | 10 | |
| 15 | 2006 | 9 | |
| 16 | Phase II study of regional chemotherapy using the hypoxic abdominal perfusion technique in advanced abdominal carcinoma. 5-FU pharmacokinetics, complications and outcome. | 2007 | 8 |
| 17 | 2003 | 7 | |
| 18 | 2013 | 7 | |
| 19 | Chemoembolization with carboplatin of the lung. Feasibility and toxicity in a pig model. | 2007 | 7 |
| 20 | Stealth liposomal 5-fluorouracil with or without degradable starch microspheres for hepatic arterial infusion in the treatment of liver metastases. An animal study in VX-2 liver tumor-bearing rabbits. | 2004 | 6 |
About U. Pohlen
U. Pohlen is a scholar working on Hepatology, Oncology, Surgery, Cancer Research and Pulmonary and Respiratory Medicine, having authored 31 papers that have together received 406 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (14 papers), Cancer, Hypoxia, and Metabolism (7 papers), Colorectal Cancer Treatments and Studies (6 papers), Nanoparticle-Based Drug Delivery (5 papers), Colorectal Cancer Surgical Treatments (4 papers), Pancreatic and Hepatic Oncology Research (4 papers), Nanoplatforms for cancer theranostics (3 papers) and Minimally Invasive Surgical Techniques (3 papers). The work is most often cited by research in Hepatology (98 citations), Oncology (197 citations), Surgery (186 citations), Pulmonary and Respiratory Medicine (114 citations) and Biomaterials (33 citations). U. Pohlen has collaborated with scholars based in Germany, United States and Netherlands. Frequent co-authors include H. J. Buhr, G. Berger, M. Kruschewski, Hubert G. Hotz, Regina Reszka, Christoph Holmer, Mike Parker, Christoph Loddenkemper, Inne H.M. Borel Rinkes and Paul Schneider. Their work appears in journals such as International Journal of Colorectal Disease, Investigational New Drugs, Journal of Surgical Research, Chemotherapy and World Journal of Surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.